Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Beyond Air, Inc.
13G/A
XAIR · 08862L202
|
5.3% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 5.3% | ||||
| Bam GP LLC | 5.3% | ||||
| Balyasny Asset Management Holdings LP | 5.3% | ||||
| Dames GP LLC | 5.3% | ||||
| Dmitry Balyasny | 5.3% | ||||
|
TXNM Energy, Inc.
13G/A
TXNM · 69349H107
|
6.4% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.4% | ||||
| Bam GP LLC | 6.4% | ||||
| Balyasny Asset Management Holdings LP | 6.4% | ||||
| Dames GP LLC | 6.4% | ||||
| Dmitry Balyasny | 6.4% | ||||
|
Talkspace, Inc
13G/A
TALK · 87427V103
|
4.1% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 4.1% | ||||
| Bam GP LLC | 4.1% | ||||
| Balyasny Asset Management Holdings LP | 4.1% | ||||
| Dames GP LLC | 4.1% | ||||
| Dmitry Balyasny | 4.1% | ||||
|
SkyWater Technology, Inc.
13G
SKYT · 83089J108
|
6.4% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.4% | ||||
| Bam GP LLC | 6.4% | ||||
| Balyasny Asset Management Holdings LP | 6.4% | ||||
| Dames GP LLC | 6.4% | ||||
| Dmitry Balyasny | 6.4% | ||||
|
Sagimet Biosciences Inc.
13G
SGMT · 786700104
|
5.9% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 5.9% | ||||
| Bam GP LLC | 5.9% | ||||
| Balyasny Asset Management Holdings LP | 5.9% | ||||
| Dames GP LLC | 5.9% | ||||
| Dmitry Balyasny | 5.9% | ||||
|
SAB Biotherapeutics, Inc.
13G/A
SABS · 78397T202
|
9.5% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 9.5% | ||||
| Bam GP LLC | 9.5% | ||||
| Balyasny Asset Management Holdings LP | 9.5% | ||||
| Dames GP LLC | 9.5% | ||||
| Dmitry Balyasny | 9.5% | ||||
|
Rezolute, Inc.
13G/A
RZLT · 76200L309
|
4.8% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 4.8% | ||||
| Bam GP LLC | 4.8% | ||||
| Balyasny Asset Management Holdings LP | 4.8% | ||||
| Dames GP LLC | 4.8% | ||||
| Dmitry Balyasny | 4.8% | ||||
|
Rallybio Corp
13G/A
RLYB · 75120L209
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 0% | ||||
| Bam GP LLC | 0% | ||||
| Balyasny Asset Management Holdings LP | 0% | ||||
| Dames GP LLC | 0% | ||||
| Dmitry Balyasny | 0% | ||||
|
Research Alliance Corporation III
13G
RACC · G75226103
|
6.4% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.4% | ||||
| Bam GP LLC | 6.4% | ||||
| Balyasny Asset Management Holdings LP | 6.4% | ||||
| Dames GP LLC | 6.4% | ||||
| Dmitry Balyasny | 6.4% | ||||
|
Quince Therapeutics, Inc.
13G
QNCX · 22053A305
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Ovid Therapeutics Inc.
13G/A
OVID · 690469101
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 4.99% | ||||
| Bam GP LLC | 4.99% | ||||
| Balyasny Asset Management Holdings LP | 4.99% | ||||
| Dames GP LLC | 4.99% | ||||
| Dmitry Balyasny | 4.99% | ||||
|
Nasus Pharma Ltd.
13G/A
NSRX · M7071P109
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Neurogene Inc.
13G
NGNE · 64135M105
|
5.2% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 5.2% | ||||
| Bam GP LLC | 5.2% | ||||
| Balyasny Asset Management Holdings LP | 5.2% | ||||
| Dames GP LLC | 5.2% | ||||
| Dmitry Balyasny | 5.2% | ||||
|
Minerva Neurosciences, Inc.
13G/A
NERV · 603380205
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Lexeo Therapeutics, Inc.
13G/A
LXEO · 52886X107
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Korro Bio, Inc.
13G/A
KRRO · 500946108
|
6.6% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.6% | ||||
| Bam GP LLC | 6.6% | ||||
| Balyasny Asset Management Holdings LP | 6.6% | ||||
| Dames GP LLC | 6.6% | ||||
| Dmitry Balyasny | 6.6% | ||||
|
Jatt II Acquisition Corp
13G
JATT · G50765109
|
6.2% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.2% | ||||
| Bam GP LLC | 6.2% | ||||
| Balyasny Asset Management Holdings LP | 6.2% | ||||
| Dames GP LLC | 6.2% | ||||
| Dmitry Balyasny | 6.2% | ||||
|
Opus Genetics Inc.
13G/A
IRD · 67577R102
|
6.6% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.6% | ||||
| Bam GP LLC | 6.6% | ||||
| Balyasny Asset Management Holdings LP | 6.6% | ||||
| Dames GP LLC | 6.6% | ||||
| Dmitry Balyasny | 6.6% | ||||
|
Helix Acquisition Corp. III
13G/A
TXNM · 69349H107
|
7.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 7.0% | ||||
| Bam GP LLC | 7.0% | ||||
| Balyasny Asset Management Holdings LP | 7.0% | ||||
| Dames GP LLC | 7.0% | ||||
| Dmitry Balyasny | 7.0% | ||||
|
Cyclerion Therapeutics, Inc.
13G
CYCN · 23255M204
|
7.3% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 7.3% | ||||
| Bam GP LLC | 7.3% | ||||
| Balyasny Asset Management Holdings LP | 7.3% | ||||
| Dames GP LLC | 7.3% | ||||
| Dmitry Balyasny | 7.3% | ||||
|
Contineum Therapeutics, Inc.
13G/A
CTNM · 21217B100
|
7.1% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 7.1% | ||||
| Bam GP LLC | 7.1% | ||||
| Balyasny Asset Management Holdings LP | 7.1% | ||||
| Dames GP LLC | 7.1% | ||||
| Dmitry Balyasny | 7.1% | ||||
|
Cellectar Biosciences, Inc.
13G
CLRB · 15117F880
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Crescent Biopharma, Inc.
13G/A
CBIO · 38000Q201
|
6.0% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 6.0% | ||||
| Bam GP LLC | 6.0% | ||||
| Balyasny Asset Management Holdings LP | 6.0% | ||||
| Dames GP LLC | 6.0% | ||||
| Dmitry Balyasny | 6.0% | ||||
|
Camp4 Therapeutics Corp.
13G/A
CAMP · 13463J101
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Balyasny Asset Management L.P. | 4.99% | ||||
| Bam GP LLC | 4.99% | ||||
| Balyasny Asset Management Holdings LP | 4.99% | ||||
| Dames GP LLC | 4.99% | ||||
| Dmitry Balyasny | 4.99% | ||||
|
Enhabit, Inc.
13G/A
EHAB · 29332G102
|
5.2% |
5/15/2026
Event 3/31/2026
|
|||
| Balyasny Asset Management L.P. | 5.2% | ||||
| Bam GP LLC | 5.2% | ||||
| Balyasny Asset Management Holdings LP | 5.2% | ||||
| Dames GP LLC | 5.2% | ||||
| Dmitry Balyasny | 5.2% | ||||
|
Verastem Inc.
13G/A
VSTM · 92337C203
|
1.6% |
5/15/2026
Event 3/31/2026
|
|||
| Balyasny Asset Management L.P. | 1.6% | ||||
| Bam GP LLC | 1.6% | ||||
| Balyasny Asset Management Holdings LP | 1.6% | ||||
| Dames GP LLC | 1.6% | ||||
| Dmitry Balyasny | 1.6% | ||||
|
Nasus Pharma Ltd
13G
IL001218553
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Korro Bio, Inc.
13G
KRRO · 500946108
|
7.2%
Checked 5% or less
|
5/15/2026
Event 3/31/2026
|
|||
| Balyasny Asset Management L.P. | 7.2% | ||||
| Bam GP LLC | 7.2% | ||||
| Balyasny Asset Management Holdings LP | 7.2% | ||||
| Dames GP LLC | 7.2% | ||||
| Dmitry Balyasny | 7.2% | ||||
|
Avalo Therapeutics Inc.
13G/A
AVTX · 05338F306
|
2.4% |
2/17/2026
Event 12/31/2025
|
|||
| Balyasny Asset Management L.P. | 2.4% | ||||
| Bam GP LLC | 2.4% | ||||
| Balyasny Asset Management Holdings LP | 2.4% | ||||
| Dames GP LLC | 2.4% | ||||
| Dmitry Balyasny | 2.4% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
ARCT · 03969T109
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Balyasny Asset Management L.P. | 0% | ||||
| Bam GP LLC | 0% | ||||
| Balyasny Asset Management Holdings LP | 0% | ||||
| Dames GP LLC | 0% | ||||
| Dmitry Balyasny | 0% | ||||
|
Spirit AeroSystems Holdings, Inc.
13G/A
SPR · 848574109
|
5.5% |
11/14/2025
Event 9/30/2025
|
|||
| Balyasny Asset Management L.P. | 5.5% | ||||
| Bam GP LLC | 5.5% | ||||
| Balyasny Asset Management Holdings LP | 5.5% | ||||
| Dames GP LLC | 5.5% | ||||
| Dmitry Balyasny | 5.5% | ||||
|
Lottery.com Inc
13G/A
LTRYW · 54570M116
|
4.0% |
11/14/2025
Event 10/3/2025
|
|||
| Balyasny Asset Management L.P. | 4.0% | ||||
| Bam GP LLC | 4.0% | ||||
| Balyasny Asset Management Holdings LP | 4.0% | ||||
| Dames GP LLC | 4.0% | ||||
| Dmitry Balyasny | 4.0% | ||||
|
Camping World Holdings, Inc
13G/A
CWH · 13462K109
|
4.0% |
11/14/2025
Event 9/30/2025
|
|||
| Balyasny Asset Management L.P. | 4.0% | ||||
| Bam GP LLC | 4.0% | ||||
| Balyasny Asset Management Holdings LP | 4.0% | ||||
| Dames GP LLC | 4.0% | ||||
| Dmitry Balyasny | 4.0% | ||||
|
Shapeways Holdings, Inc
13G/A
SHPSQ · 81947T110
|
0.9% |
8/14/2025
Event 6/30/2025
|
|||
| Balyasny Asset Management L.P. | 0.9% | ||||
| Bam GP LLC | 0.9% | ||||
| Balyasny Asset Management Holdings LP | 0.9% | ||||
| Dames GP LLC | 0.9% | ||||
| Dmitry Balyasny | 0.9% | ||||
|
Beyond Air, Inc.
13G/A
XAIR · 08862L103
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| Balyasny Asset Management L.P. | 10.0% | ||||
| Bam GP LLC | 10.0% | ||||
| Balyasny Asset Management Holdings LP | 10.0% | ||||
| Dames GP LLC | 10.0% | ||||
| Dmitry Balyasny | 10.0% | ||||
|
Hudson Pacific Properties, Inc
13G/A
HPP · 444097109
|
4.99% |
5/15/2025
Event 3/31/2025
|
|||
| Balyasny Asset Management L.P. | 4.99% | ||||
| Bam GP LLC | 4.99% | ||||
| Balyasny Asset Management Holdings LP | 4.99% | ||||
| Dames GP LLC | 4.99% | ||||
| Dmitry Balyasny | 4.99% | ||||
|
Leap Therapeutics, Inc.
13G/A
CYPH · 52187K200
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Balyasny Asset Management L.P. | 0% | ||||
| Bam GP LLC | 0% | ||||
| Balyasny Asset Management Holdings LP | 0% | ||||
| Dames GP LLC | 0% | ||||
| Dmitry Balyasny | 0% | ||||
|
Shapeways Holdings Inc
13G/A
81947T100
|
7.0% |
2/14/2025
Event 12/31/2024
|
|||
| Balyasny Asset Management L.P. | 7.0% | ||||
| Bam GP LLC | 7.0% | ||||
| Balyasny Asset Management Holdings LP | 7.0% | ||||
| Dames GP LLC | 7.0% | ||||
| Dmitry Balyasny | 7.0% | ||||